A role for PD-1 in suppressing T cell activity in human merkel cell carcinomas

被引：0
|
作者：
Dowlatshahi, M. [1 ]
Wang, L. [1 ]
Teague, J. E. [1 ]
Lichtman, M. K. [1 ]
Gehad, A. [1 ]
Watanabe, R. [1 ]
Crisler, W. J. [1 ]
Kupper, T. S. [1 ]
Clark, R. A. [1 ]
机构：
[1] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2011年 / 131卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
543
引用
收藏
页码：S91 / S91
页数：1
相关论文
共 50 条
  • [1] PD-1 blockade and T cell responses in merkel cell carcinoma
    Miller, N. J.
    Church, C.
    Fling, S.
    Kulikauskas, R.
    Ramchurren, N.
    Shinohara, M.
    Cheever, M.
    Topalian, S. L.
    Nghiem, P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S45 - S45
  • [2] Merkel polyomavirus specific transgenic T cell receptor therapy in PD-1 inhibitor refractory Merkel cell carcinoma
    Veatch, Joshua
    Paulson, Kelly
    Asano, Yuta
    McAfee, Megan
    Martin, Lauren
    Lee, Bo
    Hall, Evan
    Bhatia, Shailender
    Nghiem, Paul
    Chapuis, Aude
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (10) : 2840 - 2840
  • [3] Biomarkers of response to PD-1 inhibition in Merkel cell carcinoma
    Spassova, I
    Ugurel, S.
    Kubat, L.
    Terheyden, P.
    Hassel, J.
    Schadendorf, D.
    Becker, J. C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 5 - 5
  • [4] Role of PD-1 in Regulating T-Cell Immunity
    Jin, Hyun-Tak
    Ahmed, Rafi
    Okazaki, Taku
    NEGATIVE CO-RECEPTORS AND LIGANDS, 2011, 350 : 17 - 37
  • [5] PD-1 blockade with pembrolizumab in advanced Merkel cell carcinoma
    Ziemer, Mirjana
    ONKOLOGE, 2016, 22 (10): : 790 - 792
  • [6] Merkel polyoma virus specific T-cell receptor transgenic T-cell therapy in PD-1 inhibitor refractory Merkel cell carcinoma.
    Veatch, Joshua
    Paulson, Kelly
    Asano, Yuta
    Martin, Lauren
    Lee, Bo
    Hall, Evan Thomas
    Bhatia, Shailender
    Nghiem, Paul
    Chapuis, Aude
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] PD-1 inhibition in advanced Merkel-cell carcinoma
    Baker, Holly
    LANCET ONCOLOGY, 2016, 17 (06): : E225 - E225
  • [8] PD-1 Blockade as a therapeutic Option for metastatic Merkel Cell Carcinoma
    Winkler, J. K.
    Bender, C.
    Enk, A.
    Hassel, J. C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 : 12 - 13
  • [9] PD-1 Blockade in an HIV Patient with Metastatic Merkel Cell Carcinoma
    Gellrich, F.
    Garzarolli, M.
    Blum, S.
    Beissert, S.
    Spornraft-Ragaller, P.
    Boashie, U.
    Meier, F.
    Rauschenberg, R.
    AKTUELLE DERMATOLOGIE, 2018, 44 (06) : 268 - 272
  • [10] PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma
    Nghiem, Paul T.
    Bhatia, Shailender
    Lipson, Evan J.
    Kudchadkar, Ragini R.
    Miller, Natalie J.
    Annamalai, Lakshmanan
    Berry, Sneha
    Chartash, Elliot K.
    Daud, Adil
    Fling, Steven P.
    Friedlander, Philip A.
    Kluger, Harriet M.
    Kohrt, Holbrook E.
    Lundgren, Lisa
    Margolin, Kim
    Mitchell, Alan
    Olencki, Thomas
    Pardoll, Drew M.
    Reddy, Sunil A.
    Shantha, Erica M.
    Sharfman, William H.
    Sharon, Elad
    Shemanski, Lynn R.
    Shinohara, Michi M.
    Sunshine, Joel C.
    Taube, Janis M.
    Thompson, John A.
    Townson, Steven M.
    Yearley, Jennifer H.
    Topalian, Suzanne L.
    Cheever, Martin A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (26): : 2542 - 2552
12345